APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bifidus

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bifidus Market Outlook and Growth Opportunities 2026

5 March 2026193 pages

Choose your research edition.

Industry ResearchBifidus Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Bifidus Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Bifidus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bifidus Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Bifidus Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Bifidus market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bifidus market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bifidus market include Chr-Hansen, DuPont, Wecare Probiotics, Probi, Mitushi Bio Pharma, Scitop Bio-tech, Lallemand, Goerlich Pharma and Shandong Zhongke Jiayi Bioengineering, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bifidus market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bifidus and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bifidus sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bifidus market size, projected growth trends, production technologies, key applications, and end-use industries.

Bifidus Segment by Company

Chr-Hansen

DuPont

Wecare Probiotics

Probi

Mitushi Bio Pharma

Scitop Bio-tech

Lallemand

Goerlich Pharma

Shandong Zhongke Jiayi Bioengineering

Danone

Shanghai SPH Sinopharm

Bifidus Segment by Type

Food Grade

Pharmaceutical Grade

Bifidus Segment by Application

Food & Beverages

Medicines

Health Products

Others

Bifidus Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bifidus status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bifidus market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bifidus significant trends, drivers, influence factors in global and regions.

6. To analyze Bifidus competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifidus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bifidus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifidus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bifidus market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bifidus industry.

Chapter 3: Detailed analysis of Bifidus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bifidus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bifidus in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bifidus Industry Trends Table 2. Bifidus Industry Drivers Table 3. Bifidus Industry Opportunities and Challenges Table 4. Bifidus Industry Restraints Table 5. Global Bifidus Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bifidus Revenue Share by Company (2021-2026) Table 7. Global Bifidus Sales Volume by Company (k units) & (2021-2026) Table 8. Global Bifidus Sales Volume Share by Company (2021-2026) Table 9. Global Bifidus Average Price (USD/unit) of Company (2021-2026) Table 10. Global Bifidus Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bifidus Key Company Manufacturing Base & Headquarters Table 12. Global Bifidus Company, Product Type & Application Table 13. Global Bifidus Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bifidus by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Food Grade Table 18. Significant Companies of Pharmaceutical Grade Table 19. Global Bifidus Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Bifidus Sales Volume by Type (2021-2026) & (k units) Table 21. Global Bifidus Sales Volume by Type (2027-2032) & (k units) Table 22. Global Bifidus Sales Volume Share by Type (2021-2026) Table 23. Global Bifidus Sales Volume Share by Type (2027-2032) Table 24. Global Bifidus Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bifidus Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Bifidus Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Bifidus Sales Value Share by Type (2021-2026) Table 28. Global Bifidus Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Food & Beverages Table 30. Significant Companies of Medicines Table 31. Significant Companies of Health Products Table 32. Significant Companies of Others Table 33. Global Bifidus Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Bifidus Sales Volume by Application (2021-2026) & (k units) Table 35. Global Bifidus Sales Volume by Application (2027-2032) & (k units) Table 36. Global Bifidus Sales Volume Share by Application (2021-2026) Table 37. Global Bifidus Sales Volume Share by Application (2027-2032) Table 38. Global Bifidus Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Bifidus Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Bifidus Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Bifidus Sales Value Share by Application (2021-2026) Table 42. Global Bifidus Sales Value Share by Application (2027-2032) Table 43. Global Bifidus Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Bifidus Sales by Region (2021-2026) & (k units) Table 45. Global Bifidus Sales Market Share by Region (2021-2026) Table 46. Global Bifidus Sales by Region (2027-2032) & (k units) Table 47. Global Bifidus Sales Market Share by Region (2027-2032) Table 48. Global Bifidus Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Bifidus Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Bifidus Sales Value Share by Region (2021-2026) Table 51. Global Bifidus Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Bifidus Sales Value Share by Region (2027-2032) Table 53. Global Bifidus Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Bifidus Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Bifidus Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Bifidus Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Bifidus Sales by Country (2021-2026) & (k units) Table 58. Global Bifidus Sales Market Share by Country (2021-2026) Table 59. Global Bifidus Sales by Country (2027-2032) & (k units) Table 60. Global Bifidus Sales Market Share by Country (2027-2032) Table 61. Global Bifidus Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Bifidus Sales Value Market Share by Country (2021-2026) Table 63. Global Bifidus Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Bifidus Sales Value Market Share by Country (2027-2032) Table 65. Chr-Hansen Company Information Table 66. Chr-Hansen Business Overview Table 67. Chr-Hansen Bifidus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Chr-Hansen Bifidus Product Portfolio Table 69. Chr-Hansen Recent Development Table 70. DuPont Company Information Table 71. DuPont Business Overview Table 72. DuPont Bifidus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. DuPont Bifidus Product Portfolio Table 74. DuPont Recent Development Table 75. Wecare Probiotics Company Information Table 76. Wecare Probiotics Business Overview Table 77. Wecare Probiotics Bifidus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Wecare Probiotics Bifidus Product Portfolio Table 79. Wecare Probiotics Recent Development Table 80. Probi Company Information Table 81. Probi Business Overview Table 82. Probi Bifidus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Probi Bifidus Product Portfolio Table 84. Probi Recent Development Table 85. Mitushi Bio Pharma Company Information Table 86. Mitushi Bio Pharma Business Overview Table 87. Mitushi Bio Pharma Bifidus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Mitushi Bio Pharma Bifidus Product Portfolio Table 89. Mitushi Bio Pharma Recent Development Table 90. Scitop Bio-tech Company Information Table 91. Scitop Bio-tech Business Overview Table 92. Scitop Bio-tech Bifidus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Scitop Bio-tech Bifidus Product Portfolio Table 94. Scitop Bio-tech Recent Development Table 95. Lallemand Company Information Table 96. Lallemand Business Overview Table 97. Lallemand Bifidus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Lallemand Bifidus Product Portfolio Table 99. Lallemand Recent Development Table 100. Goerlich Pharma Company Information Table 101. Goerlich Pharma Business Overview Table 102. Goerlich Pharma Bifidus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Goerlich Pharma Bifidus Product Portfolio Table 104. Goerlich Pharma Recent Development Table 105. Shandong Zhongke Jiayi Bioengineering Company Information Table 106. Shandong Zhongke Jiayi Bioengineering Business Overview Table 107. Shandong Zhongke Jiayi Bioengineering Bifidus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Shandong Zhongke Jiayi Bioengineering Bifidus Product Portfolio Table 109. Shandong Zhongke Jiayi Bioengineering Recent Development Table 110. Danone Company Information Table 111. Danone Business Overview Table 112. Danone Bifidus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Danone Bifidus Product Portfolio Table 114. Danone Recent Development Table 115. Shanghai SPH Sinopharm Company Information Table 116. Shanghai SPH Sinopharm Business Overview Table 117. Shanghai SPH Sinopharm Bifidus Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Shanghai SPH Sinopharm Bifidus Product Portfolio Table 119. Shanghai SPH Sinopharm Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Bifidus Distributors List Table 123. Bifidus Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Bifidus Product Image Figure 2. Global Bifidus Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bifidus Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bifidus Sales (2021-2032) & (k units) Figure 5. Global Bifidus Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Bifidus Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Food Grade Image Figure 10. Pharmaceutical Grade Image Figure 11. Global Bifidus Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Bifidus Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Bifidus Sales Volume Share by Type (2021-2032) Figure 14. Global Bifidus Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Bifidus Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Bifidus Sales Value Share by Type (2021-2032) Figure 17. Food & Beverages Image Figure 18. Medicines Image Figure 19. Health Products Image Figure 20. Others Image Figure 21. Global Bifidus Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Bifidus Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Bifidus Sales Volume Share by Application (2021-2032) Figure 24. Global Bifidus Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Bifidus Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Bifidus Sales Value Share by Application (2021-2032) Figure 27. Global Bifidus Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Bifidus Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Bifidus Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Bifidus Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Bifidus Sales Value (2021-2032) & (US$ Million) Figure 32. North America Bifidus Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Bifidus Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Bifidus Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Bifidus Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Bifidus Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Bifidus Sales Value (2021-2032) & (US$ Million) Figure 38. South America Bifidus Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Bifidus Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Bifidus Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Bifidus Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Bifidus Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Bifidus Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Bifidus Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Bifidus Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Food Grade
  • Pharmaceutical Grade
Applications
  • Food & Beverages
  • Medicines
  • Health Products
  • Others
Companies covered
  • Chr-Hansen
  • DuPont
  • Wecare Probiotics
  • Probi
  • Mitushi Bio Pharma
  • Scitop Bio-tech
  • Lallemand
  • Goerlich Pharma
  • Shandong Zhongke Jiayi Bioengineering
  • Danone
  • Shanghai SPH Sinopharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bifidus Sales Value (2021-2032)
  4. 1.2.2 Global Bifidus Sales Volume (2021-2032)
  5. 1.2.3 Global Bifidus Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bifidus Market Dynamics
  1. 2.1 Bifidus Industry Trends
  2. 2.2 Bifidus Industry Drivers
  3. 2.3 Bifidus Industry Opportunities and Challenges
  4. 2.4 Bifidus Industry Restraints
3 Bifidus Market by Company
  1. 3.1 Global Bifidus Company Revenue Ranking in 2025
  2. 3.2 Global Bifidus Revenue by Company (2021-2026)
  3. 3.3 Global Bifidus Sales Volume by Company (2021-2026)
  4. 3.4 Global Bifidus Average Price by Company (2021-2026)
  5. 3.5 Global Bifidus Company Ranking (2024-2026)
  6. 3.6 Global Bifidus Company Manufacturing Base and Headquarters
  7. 3.7 Global Bifidus Company Product Type and Application
  8. 3.8 Global Bifidus Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bifidus Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bifidus Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bifidus Market by Type
  1. 4.1 Bifidus Type Introduction
  2. 4.1.1 Food Grade
  3. 4.1.2 Pharmaceutical Grade
  4. 4.2 Global Bifidus Sales Volume by Type
  5. 4.2.1 Global Bifidus Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bifidus Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Bifidus Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Bifidus Sales Value by Type
  9. 4.3.1 Global Bifidus Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bifidus Sales Value by Type (2021-2032)
  11. 4.3.3 Global Bifidus Sales Value Share by Type (2021-2032)
5 Bifidus Market by Application
  1. 5.1 Bifidus Application Introduction
  2. 5.1.1 Food & Beverages
  3. 5.1.2 Medicines
  4. 5.1.3 Health Products
  5. 5.1.4 Others
  6. 5.2 Global Bifidus Sales Volume by Application
  7. 5.2.1 Global Bifidus Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Bifidus Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Bifidus Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Bifidus Sales Value by Application
  11. 5.3.1 Global Bifidus Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Bifidus Sales Value by Application (2021-2032)
  13. 5.3.3 Global Bifidus Sales Value Share by Application (2021-2032)
6 Bifidus Regional Sales and Value Analysis
  1. 6.1 Global Bifidus Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bifidus Sales by Region (2021-2032)
  3. 6.2.1 Global Bifidus Sales by Region: 2021-2026
  4. 6.2.2 Global Bifidus Sales by Region (2027-2032)
  5. 6.3 Global Bifidus Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bifidus Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bifidus Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bifidus Sales Value by Region (2027-2032)
  9. 6.5 Global Bifidus Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bifidus Sales Value (2021-2032)
  12. 6.6.2 North America Bifidus Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bifidus Sales Value (2021-2032)
  15. 6.7.2 Europe Bifidus Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bifidus Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bifidus Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bifidus Sales Value (2021-2032)
  21. 6.9.2 South America Bifidus Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bifidus Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bifidus Sales Value Share by Country, 2025 VS 2032
7 Bifidus Country-level Sales and Value Analysis
  1. 7.1 Global Bifidus Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bifidus Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bifidus Sales by Country (2021-2032)
  4. 7.3.1 Global Bifidus Sales by Country (2021-2026)
  5. 7.3.2 Global Bifidus Sales by Country (2027-2032)
  6. 7.4 Global Bifidus Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bifidus Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bifidus Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bifidus Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bifidus Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bifidus Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bifidus Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bifidus Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bifidus Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bifidus Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bifidus Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bifidus Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bifidus Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bifidus Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bifidus Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bifidus Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bifidus Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bifidus Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bifidus Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bifidus Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bifidus Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bifidus Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bifidus Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bifidus Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bifidus Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bifidus Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bifidus Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bifidus Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bifidus Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bifidus Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bifidus Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bifidus Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bifidus Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bifidus Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bifidus Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bifidus Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bifidus Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bifidus Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bifidus Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bifidus Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bifidus Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bifidus Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bifidus Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bifidus Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bifidus Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bifidus Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bifidus Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bifidus Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bifidus Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bifidus Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bifidus Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bifidus Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bifidus Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bifidus Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bifidus Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bifidus Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bifidus Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bifidus Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bifidus Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bifidus Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bifidus Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bifidus Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bifidus Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bifidus Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bifidus Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bifidus Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bifidus Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bifidus Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bifidus Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bifidus Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bifidus Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bifidus Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bifidus Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bifidus Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bifidus Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bifidus Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bifidus Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bifidus Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bifidus Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bifidus Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bifidus Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bifidus Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bifidus Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bifidus Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bifidus Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bifidus Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bifidus Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chr-Hansen
  2. 8.1.1 Chr-Hansen Company Information
  3. 8.1.2 Chr-Hansen Business Overview
  4. 8.1.3 Chr-Hansen Bifidus Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chr-Hansen Bifidus Product Portfolio
  6. 8.1.5 Chr-Hansen Recent Developments
  7. 8.2 DuPont
  8. 8.2.1 DuPont Company Information
  9. 8.2.2 DuPont Business Overview
  10. 8.2.3 DuPont Bifidus Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 DuPont Bifidus Product Portfolio
  12. 8.2.5 DuPont Recent Developments
  13. 8.3 Wecare Probiotics
  14. 8.3.1 Wecare Probiotics Company Information
  15. 8.3.2 Wecare Probiotics Business Overview
  16. 8.3.3 Wecare Probiotics Bifidus Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Wecare Probiotics Bifidus Product Portfolio
  18. 8.3.5 Wecare Probiotics Recent Developments
  19. 8.4 Probi
  20. 8.4.1 Probi Company Information
  21. 8.4.2 Probi Business Overview
  22. 8.4.3 Probi Bifidus Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Probi Bifidus Product Portfolio
  24. 8.4.5 Probi Recent Developments
  25. 8.5 Mitushi Bio Pharma
  26. 8.5.1 Mitushi Bio Pharma Company Information
  27. 8.5.2 Mitushi Bio Pharma Business Overview
  28. 8.5.3 Mitushi Bio Pharma Bifidus Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mitushi Bio Pharma Bifidus Product Portfolio
  30. 8.5.5 Mitushi Bio Pharma Recent Developments
  31. 8.6 Scitop Bio-tech
  32. 8.6.1 Scitop Bio-tech Company Information
  33. 8.6.2 Scitop Bio-tech Business Overview
  34. 8.6.3 Scitop Bio-tech Bifidus Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Scitop Bio-tech Bifidus Product Portfolio
  36. 8.6.5 Scitop Bio-tech Recent Developments
  37. 8.7 Lallemand
  38. 8.7.1 Lallemand Company Information
  39. 8.7.2 Lallemand Business Overview
  40. 8.7.3 Lallemand Bifidus Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lallemand Bifidus Product Portfolio
  42. 8.7.5 Lallemand Recent Developments
  43. 8.8 Goerlich Pharma
  44. 8.8.1 Goerlich Pharma Company Information
  45. 8.8.2 Goerlich Pharma Business Overview
  46. 8.8.3 Goerlich Pharma Bifidus Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Goerlich Pharma Bifidus Product Portfolio
  48. 8.8.5 Goerlich Pharma Recent Developments
  49. 8.9 Shandong Zhongke Jiayi Bioengineering
  50. 8.9.1 Shandong Zhongke Jiayi Bioengineering Company Information
  51. 8.9.2 Shandong Zhongke Jiayi Bioengineering Business Overview
  52. 8.9.3 Shandong Zhongke Jiayi Bioengineering Bifidus Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shandong Zhongke Jiayi Bioengineering Bifidus Product Portfolio
  54. 8.9.5 Shandong Zhongke Jiayi Bioengineering Recent Developments
  55. 8.10 Danone
  56. 8.10.1 Danone Company Information
  57. 8.10.2 Danone Business Overview
  58. 8.10.3 Danone Bifidus Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Danone Bifidus Product Portfolio
  60. 8.10.5 Danone Recent Developments
  61. 8.11 Shanghai SPH Sinopharm
  62. 8.11.1 Shanghai SPH Sinopharm Company Information
  63. 8.11.2 Shanghai SPH Sinopharm Business Overview
  64. 8.11.3 Shanghai SPH Sinopharm Bifidus Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Shanghai SPH Sinopharm Bifidus Product Portfolio
  66. 8.11.5 Shanghai SPH Sinopharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bifidus Value Chain Analysis
  2. 9.1.1 Bifidus Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bifidus Sales Mode & Process
  6. 9.2 Bifidus Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bifidus Distributors
  9. 9.2.3 Bifidus Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst